WASHINGTON — Senator Bill Cassidy (R-La.) cited a recent change on the Centers for Disease Control and Prevention's autism website to support his endorsement of Dr. Evelyn Reed, President Trump's nominee to lead the agency. The move positions Cassidy, a physician, as a key power broker in the confirmation process and in future federal health policy.
The website update, implemented in June, reclassified certain diagnostic criteria related to early childhood development, which could affect how federal grants are allocated for autism research and intervention programs. The change aligns with the priorities of several neurodiversity advocacy groups, which have lobbied for a focus on support and inclusion over cure-focused research.
Cassidy, a senior member of the Senate Health, Education, Labor, and Pensions Committee, highlighted the change during Reed's confirmation hearing this week. His public endorsement gives critical momentum to Reed, whose nomination has drawn scrutiny from health organizations concerned about her prior work in private-sector vaccine development. Reed's confirmation requires a simple majority vote in the full Senate.
Groups like the Autistic Self Advocacy Network and the Neurodiversity Initiative increased their lobbying efforts on Capitol Hill by 30 percent over the past year, according to OpenSecrets data. Their priorities include federal funding for inclusive education programs and a reallocation of research dollars away from genetic studies. The website change is a direct win for that agenda.
Autism Speaks, which has historically focused on identifying causes and potential treatments, expressed concern about the CDC's updated language. The organization spent $1.8 million on lobbying in 2025, primarily pushing for increased biomedical research funding. The shift could redirect millions in federal grants away from its preferred research areas, affecting universities and private labs it funds.
The financial stakes are real. The National Institutes of Health allocated over $320 million to autism research in fiscal year 2025. A shift in CDC guidance typically influences NIH grant priorities and the types of projects that receive funding. Reed's leadership at the CDC would lock in this new direction, affecting grant recipients for years.
Cassidy's public embrace of the website change signals a clear political alignment with a growing faction of autism advocates. His support for Reed puts a CDC director in place who will likely champion the updated guidelines, shaping how the federal government approaches autism research and funding through the end of Trump's term.
